Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Japanese approvals for GSK, AZ and Bayer

MHLW gives Nucala, Tagrisso and Xofigo the green light

- PMLiVE

Sanofi appoints Dr Yong-Jun Liu as head of research

He brings experience from MedImmune and the Baylor Research Institute

- PMLiVE

Why health psychology should inform pharma strategy

Lucid is an award-winning agency, creating medical education designed to change healthcare professional (HCP) behaviour and in turn, changing patients’ lives. Their unique approach, known as ‘Advanced Outcomes’, focuses on...

- PMLiVE

Jenny Ousbey moves from Lexington to Westminster Advisers

She takes on the role of head of health and director

- PMLiVE

Novartis kicks back against US corruption charges

Investigation ‘explodes’ with US government information request on 79,000 physicians events

Gilead Sciences

Gilead must pay just $200m for hep C patents, says jury

Merck & Co awarded a 4% royalty rate on sales of Sovaldi and Harvoni

- PMLiVE

European bioinformatics institute appoints GSK’s Dr Andrew Leach

He joins the EMBL-EBI as head of chemistry services

- PMLiVE

Former Genzyme group vice president joins Vedanta Biosciences

Dr Bruce Roberts takes up the role of chief scientific officer

Cybersecurity

Finding a cure for pharma companies

- PMLiVE

Med comms has a ‘big role to play’ in market access

HCA meeting hears communications can assist companies with the process

- PMLiVE

Norman Lamb: Health savings ‘unachievable’ under current approach

Former minister says health system's ‘existential challenge’ needs new thinking

- PMLiVE

3D printed epilepsy drug launched in the US

Aprecia’s Spritam is now available as a prescription drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links